Léčivé přípravky s obsahem účinné látky Romiplostim

Economic Operator with Whom the Contract Has Been Concluded


Show detail
DetailS2025/00983/0020. 01. 2026Amgen s.r.o.8 725 942,317 791 019,928 725 942,317 791 019,92CZK

Published Documents


Show detail
DetailS2025/00983/00S2025_00938_00 Kupní smlouva Romiplostim_anon.pdfSmlouva26. 01. 2026 09:47Dokument není zavirovaný

List of Participants


Show detail
DetailAmgen s.r.o.Praha8 725 942,317 791 019,92CZKYesYes

Written Report - Justification


Show detail
Justification for using other means of communication for submitting bids instead of electronic means
Justification for not dividing an above-threshold public procurement into lots
Justification for setting requirements for proving turnover in case of proceeding according to Article 78(3), if not stated in the tender documentation
Detailpovaha zakázky to neumožňujenestanoveno